The role of echocardiographic deformation imaging in hypertrophic myopathies

Nature Reviews Cardiology

Volumn 7, Issue 7, 2010, Pages 384-396

  Cikes, Maja ^a   Sutherland, George R ^b   Anderson, Lisa J ^b   Bijnens, Bart H ^c  

^a KBC Zagreb   (Croatia)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IDEBENONE;

AMYLOIDOSIS; AORTA STENOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOPPLER ECHOCARDIOGRAPHY; DUCHENNE MUSCULAR DYSTROPHY; ECHOCARDIOGRAPHY; EXERCISE; FABRY DISEASE; FOLLOW UP; FRIEDREICH ATAXIA; HEART AMYLOIDOSIS; HEART HYPERTROPHY; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART VENTRICLE OVERLOAD; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; M MODE ECHOCARDIOGRAPHY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTOLE;

CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY, DOPPLER; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 77954177637     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2010.56     Document Type: Review

References (137)

1. Sutherland, G. R., Hatle, L., Claus, P., D'hooge, J. & Bijnens, B. (Eds) Doppler Myocardial Imaging, A Textbook (BSWK bvba, Hasselt, Belgium, 2006).
2. Sengupta, P. P. et al. Left ventricular form and function revisited: applied translational science to cardiovascular ultrasound imaging. J. Am. Soc. Echocardiogr. 20, 539-551 (2007).
3. Grossman, W., Jones, D. & McLaurin, L. P. Wall stress and patterns of hypertrophy in the human left ventricle. J. Clin. Invest. 56, 56-64 (1975).
4. Opie, L. H., Commerford, P. J., Gersh, B. J. & Pfeffer, M. A. Controversies in ventricular remodelling. Lancet 367, 356-367 (2006).
5. Baltabaeva, A. et al. Regional left ventricular deformation and geometry analysis provides insights in myocardial remodelling in mild to moderate hypertension. Eur. J. Echocardiogr. 9, 501-508 (2008).
6. Lang, R. M. et al. Recommendations for chamber quantification. Eur. J. Echocardiogr. 7, 79-108 (2006).
7. Bijnens, B., Claus, P., Weidemann, F., Strotmann, J. & Sutherland, G. R. Investigating cardiac function using motion and deformation analysis in the setting of coronary artery disease. Circulation 116, 2453-2464 (2007).
8. Aurigemma, G. P., Silver, K. H., Priest, M. A. & Gaasch, W. H. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J. Am. Coll. Cardiol. 26, 195-202 (1995).
9. Bijnens, B. H., Cikes, M., Claus, P. & Sutherland, G. R. Velocity and deformation imaging for the assessment of myocardial dysfunction. Eur. J. Echocardiogr. 10, 216-226 (2009).
10. Claus, P. et al. Mechanisms of postsystolic thickening in ischemic myocardium: mathematical modelling and comparison with experimental ischemic substrates. Ultrasound Med. Biol. 33, 1963-1970 (2007).
11. Greenbaum, R. A., Ho, S. Y., Gibson, D. G., Becker, A. E. & Anderson, R. H. Left ventricular fibre architecture in man. Br. Heart J. 45, 248-263 (1981).
12. Beyar, R., Yin, F. C., Hausknecht, M., Weisfeldt, M. L. & Kass, D. A. Dependence of left ventricular twist-radial shortening relations on cardiac cycle phase. Am. J. Physiol. 257, H1119-H1126 (1989).
13. Saito, K. et al. Comprehensive evaluation of left ventricular strain using speckle tracking echocardiography in normal adults: comparison of three-dimensional and two-dimensional approaches. J. Am. Soc. Echocardiogr. 22, 1025-1030 (2009).
14. Kowalski, M. et al. Can natural strain and strain rate quantify regional myocardial deformation? A study in healthy subjects. Ultrasound Med. Biol. 27, 1087-1097 (2001).
15. Serri, K. et al. Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 47, 1175-1181 (2006).
16. Langeland, S. et al. Experimental assessment of a new research tool for the estimation of twodimensional myocardial strain. Ultrasound Med. Biol. 32, 1509-1513 (2006).
17. Korinek, J. et al. Two-dimensional strain-a Doppler-independent ultrasound method for quantitation of regional deformation: validation in vitro and in vivo. J. Am. Soc. Echocardiogr. 18, 1247-1253 (2005).
18. Ng, A. C. et al. Comparison of myocardial tissue velocities measured by two-dimensional speckle tracking and tissue Doppler imaging. Am. J. Cardiol. 102, 784-789 (2008).
19. Chan, J. et al. Differentiation of subendocardial and transmural infarction using two-dimensional strain rate imaging to assess short-axis and long-axis myocardial function. J. Am. Coll. Cardiol. 48, 2026-2033 (2006).
20. Jamal, F. et al. Noninvasive quantification of the contractile reserve of stunned myocardium by ultrasonic strain rate and strain. Circulation 104, 1059-1065 (2001).
21. Weidemann, F. et al. Myocardial function defined by strain rate and strain during alterations in inotropic states and heart rate. Am. J. Physiol. Heart Circ. Physiol. 283, H792-H799 (2002).
22. Thibault, H. & Derumeaux, G. Assessment of myocardial ischemia and viability using tissue Doppler and deformation imaging: the lessons from the experimental studies. Arch. Cardiovasc. Dis. 101, 61-68 (2008).
23. Voigt, J. U. et al. Comparison of deformation imaging and velocity imaging for detecting regional inducible ischaemia during dobutamine stress echocardiography. Eur. Heart J. 25, 1517-1525 (2004).
24. Marciniak, A. et al. Changes in systolic left ventricular function in isolated mitral regurgitation. A strain rate imaging study. Eur. Heart J. 28, 2627-2636 (2007).
25. Marciniak, A. et al. Myocardial deformation abnormalities in patients with aortic regurgitation: a strain rate imaging study. Eur. J. Echocardiogr. 10, 112-119 (2009).
26. Kato, T. S. et al. Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue doppler ultrasonography. Circulation 110, 3808-3814 (2004).
27. Eroglu, E. et al. Quantitative dobutamine stress echocardiography for the early detection of cardiac allograft vasculopathy in heart transplant recipients. Heart 94, e3 (2008).
28. Breithardt, O. A. et al. Cardiac resynchronization therapy can reverse abnormal myocardial strain distribution in patients with heart failure and left bundle branch block. J. Am. Coll. Cardiol. 42, 486-494 (2003).
29. Bellavia, D. et al. Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography. Am. J. Cardiol. 101, 1039-1045 (2008).
30. Weidemann, F. et al. The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease. Eur. Heart J. 26, 1221-1227 (2005).
31. Mertens, L. et al. Early regional myocardial dysfunction in young patients with Duchenne muscular dystrophy. J. Am. Soc. Echocardiogr. 21, 1049-1054 (2008).
32. Perseghin, G. et al. Effect of the sporting discipline on the right and left ventricular morphology and function of elite male track runners: a magnetic resonance imaging and phosphorus 31 spectroscopy study. Am. Heart J. 154, 937-942 (2007).
33. Pluim, B. M. et al. Functional and metabolic evaluation of the athlete's heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy. Circulation 97, 666-672 (1998).
34. Abergel, E. et al. Serial left ventricular adaptations in world-class professional cyclists: implications for disease screening and follow-up. J. Am. Coll. Cardiol. 44, 144-149 (2004).
35. Morganroth, J., Maron, B. J., Henry, W. L. & Epstein, S. E. Comparative left ventricular dimensions in trained athletes. Ann. Intern. Med. 82, 521-524 (1975).
36. D'Andrea, A. et al. Association between left ventricular structure and cardiac performance during effort in two morphological forms of athlete's heart. Int. J. Cardiol. 86, 177-184 (2002).
37. Blomqvist, C. G. & Saltin, B. Cardiovascular adaptations to physical training. Annu. Rev. Physiol. 45, 169-189 (1983).
38. Derumeaux, G. et al. Tissue Doppler imaging differentiates physiological from pathological pressure-overload left ventricular hypertrophy in rats. Circulation 105, 1602-1608 (2002).
39. Medugorac, I. Myocardial collagen in different forms of heart hypertrophy in the rat. Res. Exp. Med. 177, 201-211 (1980).
40. Moore, R. L. & Korzick, D. H. Cellular adaptations of the myocardium to chronic exercise. Prog. Cardiovasc. Dis. 37, 371-396 (1995).
41. Vinereanu, D. et al. Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. Am. J. Cardiol. 88, 53-58 (2001).
42. Caso, P. et al. Pulsed Doppler tissue imaging in endurance athletes: relation between left ventricular preload and myocardial regional diastolic function. Am. J. Cardiol. 85, 1131-1136 (2000).
43. Herbots, L. Assessment of contractile function in endurance trained athletes using strain rate and strain. Thesis, University Hospital Gasthuisberg, Leuven, Belgium (2006).
44. Teske, A. J. et al. Echocardiographic deformation imaging reveals preserved regional systolic function in endurance athletes with left ventricular hypertrophy. Br. J. Sports Med. doi:10.1136/bjsm.2008.054346.
45. Palka, P., Lange, A. & Nihoyannopoulos, P. The effect of long-term training on age-related left ventricular changes by Doppler myocardial velocity gradient. Am. J. Cardiol. 84, 1061-1067 (1999).
46. D'Andrea, A. et al. The usefulness of Doppler myocardial imaging in the study of the athlete's heart and in the differential diagnosis between physiological and pathological ventricular hypertrophy. Echocardiography 23, 149-157 (2006).
47. Poulsen, S. H. et al. Strain rate and tissue tracking imaging in quantitation of left ventricular systolic function in endurance and strength athletes. Scand. J. Med. Sci. Sports 17, 148-155 (2007).
48. Richand, V. et al. An ultrasound speckle tracking (two-dimensional strain) analysis of myocardial deformation in professional soccer players compared with healthy subjects and hypertrophic cardiomyopathy. Am. J. Cardiol. 100, 128-132 (2007).
49. Ganau, A. et al. Patterns of left ventricular hypertrophy and geometrical remodeling in essential hypertension. J. Am. Coll. Cardiol. 19, 1550-1558 (1992).
50. Hatford, M., Wikstrand, J. C., Wallentin, I., Ljungman, S. M. & Berglund, G. L. Left ventricular wall stress and systolic function in untreated primary hypertension. Hypertension 7, 97-104 (1985).
51. Przewlocka-Kosmala, M., Kosmala, W. & Mazurek, W. Left ventricular circumferential function in patients with essential hypertension. J. Hum. Hypertens. 20, 666-671 (2006).
52. Park, S. J. et al. Left ventricular torsion by twodimensional speckle tracking echocardiography in patients with diastolic dysfunction and normal ejection fraction. J. Am. Soc. Echocardiogr. 21, 1129-1137 (2008).
53. Kosmala, W. et al. Progression of left ventricular functional abnormalities in hypertensive patients with heart failure: an ultrasonic two-dimensional speckle tracking study. J. Am. Soc. Echocardiogr. 21, 1309-1317 (2008).
54. Palmon, L. C. et al. Intramural myocardial shortening in hypertensive left ventricular hypertrophy with normal pump function. Circulation 89, 122-131 (1994).
55. Heng, M. K., Janz, R. F. & Jobin, J. Estimation of regional stress in the left ventricular septum and free wall: an echocardiographic study suggesting a mechanism for asymmetric septal hypertrophy. Am. Heart J. 110, 84-90 (1985).
56. Orlando, S. et al. Hypertrophic cardiomyopathy can be effectively discriminated from other forms of hypertrophy by the presence of localised non-deforming segments-a deformation imaging study [abstract]. Eur. Heart J. 28 (Suppl. 1), 2190 (2007).
57. Strotmann, J. M. et al. Functional differences of left ventricular hypertrophy induced by either arterial hypertension or aortic valve stenosis. Am. J. Cardiol. 101, 1493-1497 (2008).
58. Schwartzkopff, B. et al. Morphometric investigation of human myocardium in arterial hypertension and valvular aortic stenosis. Eur. Heart J. 13 (Suppl. D), 17-23 (1992).
59. Kowalski, M. et al. One-dimensional ultrasonic strain and strain rate imaging: a new approach to the quantitation of regional myocardial function in patients with aortic stenosis. Ultrasound Med. Biol. 29, 1085-1092 (2003).
60. Weidemann, F. et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 120, 577-584 (2009).
61. Carasso, S. et al. Differential effects of afterload on left ventricular long- and short-axis function: insights from a clinical model of patients with aortic valve stenosis undergoing aortic valve replacement. Am. Heart J. 158, 540-545 (2009).
62. Donal, E. et al. Influence of afterload on left ventricular radial and longitudinal systolic functions: a two-dimensional strain imaging study. Eur. J. Echocardiogr. 10, 914-921 (2009).
63. Hein, S. et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107, 984-991 (2003).
64. Cappelli, F. et al. Adaptative or maladaptative hypertrophy, different spatial distribution of myocardial contraction. Clin. Physiol. Funct. Imaging 30, 6-12 (2010).
65. Stuber, M. et al. Alterations in the local myocardial motion pattern in patients suffering from pressure overload due to aortic stenosis. Circulation 100, 361-368 (1999).
66. Sandstede, J. J. et al. Cardiac systolic rotation and contraction before and after valve replacement for aortic stenosis: a myocardial tagging study using MR imaging. AJR Am. J. Roentgenol. 178, 953-958 (2002).
67. Van Der Toorn, A. et al. Transmural gradients of cardiac myofiber shortening in aortic valve stenosis patients using MRI tagging. Am. J. Physiol. Heart Circ. Physiol. 283, H1609-H1615 (2002).
68. Lumens, J., Delhaas, T., Arts, T., Cowan, B. R. & Young, A. A. Impaired subendocardial contractile myofiber function in asymptomatic aged humans, as detected using MRI. Am. J. Physiol. Heart Circ. Physiol. 291, H1573-H1579 (2006).
69. Rutz, A. K. et al. Altered myocardial motion pattern in Fabry patients assessed with CMR-tagging. J. Cardiovasc. Magn. Reson. 9, 891-898 (2007).
70. Elliott, P. et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 29, 270-276 (2008).
71. Maron, B. J. et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur. Heart J. 24, 1965-1991 (2003).
72. Elliott, P. & McKenna, W. J. Hypertrophic cardiomyopathy. Lancet 363, 1881-1891 (2004).
73. Niimura, H. et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N. Engl. J. Med. 338, 1248-1257 (1998).
74. Maron, B. J. et al. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosinbinding protein C gene mutations. J. Am. Coll. Cardiol. 38, 315-321 (2001).
75. Charron, P. et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation 96, 214-219 (1997).
76. Richardson, P. et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93, 841-842 (1996).
77. Shapiro, L. M. & McKenna, W. J. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J. Am. Coll. Cardiol. 2, 437-444 (1983).
78. Charron, P. et al. Accuracy of European diagnostic criteria for familial hypertrophic cardiomyopathy in a genotyped population. Int. J. Cardiol. 90, 33-38 (2003).
79. Conrady, A. O. et al. Prevalence and determinants of left ventricular hypertrophy and remodelling patterns in hypertensive patients: the St. Petersburg study. Blood Press. 13, 101-109 (2004).
80. Nagueh, S. F. et al. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation 99, 254-261 (1999).
81. Severino, S. et al. Use of pulsed Doppler tissue imaging to assess regional left ventricular diastolic dysfunction in hypertrophic cardiomyopathy. Am. J. Cardiol. 82, 1394-1398 (1998).
82. Maron, B. J. et al. Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 10, 733-742 (1987).
83. Connelly, K. A. et al. Load sensitive measures may overestimate global systolic function in the presence of left ventricular hypertrophy: a comparison with load-insensitive measures. Am. J. Physiol. Heart Circ. Physiol. 290, H1699-H1705 (2006).
84. Shimizu, G. et al. Left ventricular midwall mechanics in systemic arterial hypertension: myocardial function is depressed in pressureoverload hypertrophy. Circulation 83, 1676-1684 (1991).
85. Sengupta, P. P., Mehta, V., Arora, R., Mohan, J. C. & Khandheria, B. K. Quantification of regional nonuniformity and paradoxical intramural mechanics in hypertrophic cardiomyopathy by high frame rate ultrasound myocardial strain mapping. J. Am. Soc. Echocardiogr. 18, 737-742 (2005).
86. Maron, B. J., Anan, T. J. & Roberts, W. C. Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Circulation 63, 882-894 (1981).
87. Geisterfer-Lowrance, A. A. et al. A mouse model of familial hypertrophic cardiomyopathy. Science 272, 731-734 (1996).
88. Karlon, W. J., McCulloch, A. D., Covell, J. W., Hunter, J. J. & Omens, J. H. Regional dysfunction correlates with myofiber disarray in transgenic mice with ventricular expression of ras. Am. J. Physiol. Heart Circ. Physiol. 278, H898-H906 (20s00).
89. Chang, S. A. et al. Left ventricular twist mechanics in patients with apical hypertrophic cardiomyopathy: assessment with 2D speckle tracking echocardiography. Heart 96, 49-55 (2010).
90. van Dalen, B. M. et al. Influence of the pattern of hypertrophy on left ventricular twist in hypertrophic cardiomyopathy. Heart 95, 657-661 (2009).
91. Rajiv, C., Vinereanu, D. & Fraser, A. G. Tissue Doppler imaging for the evaluation of patients with hypertrophic cardiomyopathy. Curr. Opin. Cardiol. 19, 430-436 (2004).
92. Ito, T., Suwa, M., Tonari, S., Okuda, N. & Kitaura, Y. Regional postsystolic shortening in patients with hypertrophic cardiomyopathy: its incidence and characteristics assessed by strain imaging. J. Am. Soc. Echocardiogr. 19, 987-993 (2006).
93. Yang, H. et al. Use of strain imaging in detecting segmental dysfunction in patients with hypertrophic cardiomyopathy. J. Am. Soc. Echocardiogr. 16, 233-239 (2003).
94. Ganame, J. et al. Regional myocardial deformation in children with hypertrophic cardiomyopathy: morphological and clinical correlations. Eur. Heart J. 28, 2886-2894 (2007).
95. Weidemann, F. et al. A new echocardiographic approach for the detection of non-ischaemic fibrosis in hypertrophic myocardium. Eur. Heart J. 28, 3020-3026 (2007).
96. Sun, J. P. et al. Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography. Am. J. Cardiol. 103, 411-415 (2009).
97. Kato, T. S. et al. Heterogeneity of regional systolic function detected by tissue Doppler imaging is linked to impaired global left ventricular relaxation in hypertrophic cardiomyopathy. Heart 94, 1302-1306 (2008).
98. Dong, S. J. et al. Left ventricular wall thickness and regional systolic function in patients with hypertrophic cardiomyopathy. A threedimensional tagged magnetic resonance imaging study. Circulation 90, 1200-1209 (1994).
99. Kim, Y. J. et al. Delayed enhancement in hypertrophic cardiomyopathy: comparison with myocardial tagging MRI. J. Magn. Reson. Imaging 27, 1054-1060 (2008).
100. Piella, G. et al. Myocardial deformation from tagged MRI in hypertrophic cardiomyopathy using an efficient registration strategy. Proc. SPIE 7262, 726226 (2009).
101. Moon, J. C. et al. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I. Heart 91, 1036-1040 (2005).
102. Falk, R. H. Diagnosis and management of the cardiac amyloidoses. Circulation 112, 2047-2060 (2005).
103. Dubrey, S. W. et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 91, 141-157 (1998).
104. Kyle, R. A. & Gertz, M. A. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin. Hematol. 32, 45-59 (1995).
105. Robbins, M. A., Pizzarello, R. A., Stechel, R. P., Chiaramida, S. A. & Gulotta, S. J. Resting and exercise hemodynamics in constrictive pericarditis and a case of cardiac amyloidosis mimicking constriction. Cathet. Cardiovasc. Diagn. 9, 463-471 (1983).
106. Westermark, P., Sletten, K., Johansson, B. & Cornwell, G. G. 3rd. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Natl Acad. Sci. USA 87, 2843-2845 (1990).
107. Ng, B., Connors, L. H., Davidoff, R., Skinner, M. & Falk, R. H. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated (AL) amyloidosis. Arch. Intern. Med. 165, 1425-1429 (2005).
108. Wright, J. R. & Calkins, E. Amyloid in the aged heart: frequency and clinical significance. J. Am. Geriatr. Soc. 23, 97-103 (1975).
109. Ardehali, H. et al. Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy. Am. Heart J. 147, 919-923 (2004).
110. Klein, A. L. et al. Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. J. Am. Coll. Cardiol. 16, 1135-1141 (1990).
111. Shah, K. B., Inoue, Y. & Mehra, M. R. Amyloidosis and the heart: a comprehensive review. Arch. Intern. Med. 166, 1805-1813 (2006).
112. Brenner, D. A. et al. Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ. Res. 94, 1008-1010 (2004).
113. Koyama, J., Ray-Sequin, P. A., Davidoff, R. & Falk, R. H. Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am. J. Cardiol. 89, 1067-1071 (2002).
114. Koyama, J., Davidoff, R. & Falk, R. H. Longitudinal myocardial velocity gradient derived from pulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction. J. Am. Soc. Echocardiogr. 17, 36-44 (2004).
115. Koyama, J., Ray-Sequin, P. A. & Falk, R. H. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 107, 2446-2452 (2003).
116. Maceira, A. M. et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111, 186-193 (2005).
117. Weidemann, F. et al. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment. Circulation 119, 524-529 (2009).
118. Buyse, G. et al. Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring. Neurology 60, 1679-1681 (2003).
119. Weidemann, F. et al. Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation 108, 1299-1301 (2003).
120. Dutka, D. P. et al. Echocardiographic characterization of cardiomyopathy in Friedreich's ataxia with tissue Doppler echocardiographically derived myocardial velocity gradients. Circulation 102, 1276-1282 (2000).
121. Pieroni, M. et al. Early detection of Fabry cardiomyopathy by tissue Doppler imaging. Circulation 107, 1978-1984 (2003).
122. Eng, C. M., Ioannou, Y. A. & Desnick, R. J. in The Metabolic and Molecular Bases of Inherited Disease 8th edn (eds Scriver, C. R. et al.) 3733-3774 (McGraw-Hill, New York, 2001).
123. Meikle, P. J., Hopwood, J. J., Clague, A. E. & Carey, W. F. Prevalence of lysosomal storage disorders. JAMA 281, 249-254 (1999).
124. Mehta, A. et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur. J. Clin. Invest. 34, 236-242 (2004).
125. Linhart, A. et al. New insights in cardiac structural changes in patients with Fabry's disease. Am. Heart J. 139, 1101-1108 (2000).
126. Weidemann, F. & Strotmann, J. M. Use of tissue Doppler imaging to identify and manage systemic diseases. Clin. Res. Cardiol. 97, 65-73 (2008).
127. Bogaert, J. & Rademakers, F. E. Regional nonuniformity of normal adult human left ventricle. Am. J. Physiol. Heart Circ. Physiol. 280, H610-H620 (2001).
128. Moon, J. C. et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson- Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur. Heart J. 24, 2151-2155 (2003).
129. Eng, C. M. et al. Safety and efficacy of recombinant human alpha-galactosidase A- replacement therapy in Fabry's disease. N. Engl. J. Med. 345, 9-16 (2001).
130. Beer, M. et al. Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy. Am. J. Cardiol. 97, 1515-1518 (2006).
131. Bradley, J. L. et al. Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. Hum. Mol. Genet. 9, 275-282 (2000).
132. Hewer, R. The heart in Friedreich's ataxia. Br. Heart J. 31, 5-14 (1969).
133. Child, J. S. et al. Cardiac involvement in Friedreich's ataxia: a clinical study of 75 patients. J. Am. Coll. Cardiol. 7, 1370-1378 (1986).
134. Weidemann, F. et al. Quantification of regional right and left ventricular function by ultrasonic strain rate and strain indexes in Friedreich's ataxia. Am. J. Cardiol. 91, 622-626 (2003).
135. Rustin, P. et al. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet 354, 477-479 (1999).
136. Biggar, W. D. Duchenne muscular dystrophy. Pediatr. Rev. 27, 83-88 (2006).
137. Hoffman, E. P., Brown, R. H. Jr & Kunkel, L. M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51, 919-928 (1987).